查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2137158

第四代Fluoroquinolones市場：全球市場預測，2026-2032年

Fourth Generation Fluoroquinolones Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，第四代Fluoroquinolones市場規模將達到 9.3432 億美元，年複合成長率為 8.51%。

主要市場統計數據
基準年 2025 5.2743億美元
預計年份：2026年 5.7216億美元
預測年份 2032 9.3432億美元
複合年成長率 (%) 8.51%

第四代Fluoroquinolones藥物：概述

第四代Fluoroquinolones抗生素是頻譜抗菌藥物，其作用機轉是透過抑制細菌DNA促旋酶和拓樸異構酶IV來治療某些呼吸道感染和其他細菌感染疾病。其臨床應用受多種因素影響，包括病原體感染疾病、治療指南、合理的抗菌藥物使用政策、監管要求以及Fluoroquinolones抗生素的安全性。本執行摘要概述了影響臨床應用、藥物可近性、研究和合理使用的因素，但未提供市場估算或預測。

合理用藥和抗藥性問題正在改變藥物在臨床實務中的使用方式。

目前的趨勢是從廣泛、經驗性的處方轉向以微生物檢測、區域抗菌藥物敏感性檢測和指南選擇為基礎的更有針對性的治療。對Fluoroquinolones抗藥性、醫療相關感染和副作用的擔憂，促使人們更加關注適應症、劑量、給藥持續時間、基於腎功能的劑量調整、藥物交互作用以及患者選擇。監管機構和醫療系統越來越強調僅在預期獲益大於風險的情況下才限制使用這些藥物，同時感染預防計畫也在努力減少可避免的抗藥性菌株暴露和傳播。

利用人工智慧增強監控和決策支持

人工智慧 (AI) 可以透過識別實驗室和電子健康記錄數據中的抗藥性模式、改進抗生素使用監測以及協助臨床醫生解讀複雜的患者和微生物資訊來支持這一領域。機器學習工具也有助於早期發現治療失敗、不利事件徵兆和疫情爆發。然而，其價值取決於數據的代表性、透明的檢驗、互通性、網路安全以及臨床醫生的監督。人工智慧應作為培養結果、藥敏試驗、處方指導和藥物安全監測等流程的補充，而非替代。

區域洞察：獲取資源方面的差異和通用的合理使用優先事項

北美地區的特點是嚴格的安全資訊傳播、系統的抗菌藥物管理（IPS）以及強大的檢測能力；而拉丁美洲則存在醫療系統間診斷可及性差異以及IPS法規不一致的問題。歐洲將強大的IPS框架與協調一致的抗菌藥物抗藥性監測相結合；中東地區則仍在努力平衡專科醫療機構的能力與處方監管和感染控制實施水平的差異。非洲的優先事項包括可靠的診斷、藥物可近性和加強的監測基礎設施。亞太地區的情況則高度複雜，既有先進的醫院網路和成熟的IPS項目，也有因上市藥物可及性差、監管分散以及微生物檢測能力有限而導致抗菌藥物抗藥性防治工作面臨挑戰的情況。

群體特定視角：跨國集團間政策一致性的差異

東協成員國面臨監管架構、醫療資源和抗菌藥物取得方式的差異，因此區域協調在監測和合理用藥管理方面至關重要。金磚國家擁有龐大且多元化的患者群體、檢測能力參差不齊，以及影響合理用藥的獨特國家政策。歐盟受益於協調一致的公共衛生舉措和跨境監測，而七國集團（G7）國家通常將強力的法律規範與先進的診斷技術和藥物安全監測相結合。海灣合作理事會（GCC）成員國的醫療系統通常擁有充足的醫院容量，但必須應對來自國外的抗藥性菌流入和處方模式的差異。北約成員國則面臨著與準備工作、部署環境和感染控制能力的持續性相關的額外挑戰。

國家層面的洞見：國家體系如何影響合理使用

澳洲、加拿大、法國、德國、義大利、英國、英國和美國通常擁有成熟的監管、診斷和藥物使用管理體系，但處方模式和抗藥性會因具體情況而異。巴西、墨西哥、俄羅斯、印度、中國、日本和韓國在醫院容量、監管執法、實驗室可近性、當地流行病學狀況以及公共和私營部門醫療保健服務體係等方面呈現出不同的組合。澳洲、日本和韓國高度重視先進的臨床基礎設施和監測，而印度、巴西、墨西哥、中國和俄羅斯仍在努力應對規模、地理差異和可及性方面的挑戰。在所有列出的國家，治療決策都應遵循最新的國家指南、藥敏試驗數據和已批准的附加檔。

領導者行動指南：取得、合理使用與實證合作

行業領導者應優先考慮產生能夠解決臨床相關病原體、抗藥性感染疾病、患者安全以及真實臨床實踐中治療結果問題的證據。他們還應加強與實驗室和醫療保健系統的合作，以支持高品質的抗生素使用和抗藥性監測，並提供關於適應症、禁忌症、相互作用和監測的清晰教育。營運重點包括可靠的供應、負責任的分銷、透明的安全資訊傳播以及快速的藥物安全監測。領導者還應根據臨床和公平性標準評估人工智慧工具，以確保數位化決策支援可審計，並符合合理使用抗生素的目標。

調查方法：基於證據的質性整合

本執行摘要以第四代Fluoroquinolones抗菌藥物的既定市場範圍為基礎，從臨床、監管、流行病學、技術和地理等角度系統地評估了該類藥物。分析重點在於已確立的證據主題，例如抗菌藥物抗藥性、合理用藥、診斷、安全監測、醫療系統能力和負責任的部署。區域、群體和國家層級的具體考量反映了醫療服務結構和政策環境的結構性差異，而非市場預測。在實際應用之前，應根據現行監管文件、治療指南、抗菌藥物抗藥性監測報告、同行評審研究和國家公共衛生資訊來源對相關聲明進行檢驗。

結論：負責任的定位是核心策略挑戰。

第四代Fluoroquinolones抗生素的未來角色不僅在於其廣泛應用，更在於精準的臨床定位、可靠的診斷、抗藥性控制以及持續的安全性監測。儘管區域、跨國公司和國家層面的差異需要進行在地化實施，但諸如適應症選擇、循證用藥療程、監測和合理用藥等通用原則仍然具有普遍意義。整合臨床證據、監測、數位化工具和公平取得途徑的機構將更有能力支持有效治療，同時保障此類抗生素的長期效用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：第四代Fluoroquinolones藥物市場：依產品類型分類

  • 德拉沙星
  • 加替沙星
  • 吉米沙星
  • 莫西沙星

第8章：第四代Fluoroquinolones藥物市場：依給藥途徑分類

  • 靜脈
  • 眼科
  • 口服

第9章：第四代Fluoroquinolones藥物市場：依應用領域分類

  • 眼部感染疾病
  • 胃腸道感染疾病
  • 呼吸道感染疾病
  • 皮膚和軟組織感染疾病
  • 尿道感染

第10章：第四代Fluoroquinolones藥物市場：依分銷管道分類

  • 醫院藥房
    • 住院病人藥房
    • 門診藥房
  • 網路藥房
    • 院內線上藥房
    • 第三方營運的線上藥房
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房

第11章：第四代Fluoroquinolones藥物市場：依最終用戶分類

  • 診所
    • 診斷診所
    • 基層醫療診所
  • 居家醫療
    • 由看護者管理
    • 自我管理
  • 醫院
    • 私立醫院
    • 公立醫院

第12章：第四代Fluoroquinolones藥物市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：第四代Fluoroquinolones藥物市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：第四代Fluoroquinolones藥物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Bayer Aktiengesellschaft
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.

第17章 主要專家

Product Code: MRR-961F26FD7FCB

The Fourth Generation Fluoroquinolones Market is projected to grow by USD 934.32 million at a CAGR of 8.51% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 527.43 million
Estimated Year [2026] USD 572.16 million
Forecast Year [2032] USD 934.32 million
CAGR (%) 8.51%

Fourth-Generation Fluoroquinolones: Executive Overview

Fourth-generation fluoroquinolones are broad-spectrum antibacterial medicines designed to address selected respiratory and other bacterial infections through activity against bacterial DNA gyrase and topoisomerase IV. Their clinical role is shaped by pathogen susceptibility, treatment guidelines, antimicrobial-stewardship policies, regulatory requirements, and the safety profile associated with fluoroquinolone use. This executive summary reviews the forces influencing clinical adoption, access, research, and responsible use without presenting market estimates or forecasts.

Stewardship and Resistance Are Reshaping Clinical Use

The landscape is shifting from broad empirical prescribing toward more targeted therapy supported by microbiological testing, local antibiograms, and guideline-based selection. Fluoroquinolone resistance, healthcare-associated infections, and concerns about adverse effects have increased scrutiny of indication, dose, duration, renal adjustment, drug interactions, and patient selection. Regulators and health systems increasingly emphasize reserving these medicines for situations in which expected benefits outweigh risks, while infection-prevention programs seek to reduce avoidable exposure and transmission of resistant organisms.

Artificial Intelligence Strengthens Surveillance and Decision Support

Artificial intelligence can support this field by identifying resistance patterns from laboratory and electronic health-record data, improving antimicrobial-use surveillance, and helping clinicians interpret complex patient and microbiology information. Machine-learning tools may also assist with early detection of treatment failure, adverse-event signals, and outbreaks. However, their value depends on representative data, transparent validation, interoperability, cybersecurity, and clinician oversight. AI should complement-not replace-culture results, susceptibility testing, prescribing guidance, and pharmacovigilance processes.

Regional Insights: Uneven Access Meets Common Stewardship Priorities

North America is characterized by stringent safety communication, structured stewardship, and extensive laboratory capacity, while Latin America faces uneven diagnostic access and variable antimicrobial regulation across health systems. Europe combines strong stewardship frameworks with coordinated resistance surveillance, and the Middle East continues to balance specialist-care capacity with differences in prescribing oversight and infection-control implementation. Africa's priorities include reliable diagnostics, medicine availability, and strengthening surveillance infrastructure. Asia-Pacific presents substantial diversity, ranging from advanced hospital networks and established stewardship programs to settings where over-the-counter access, fragmented regulation, and limited microbiology capacity complicate resistance control.

Group Insights: Policy Alignment Varies Across Multinational Blocs

ASEAN members are navigating differing regulatory systems, healthcare resources, and antimicrobial-access practices, making regional coordination important for surveillance and stewardship. BRICS countries bring large and diverse patient populations, varied laboratory capacity, and distinct national policies that influence responsible use. The European Union benefits from coordinated public-health initiatives and cross-border surveillance, while the G7 generally combines strong regulatory oversight with advanced diagnostics and pharmacovigilance. GCC health systems often have substantial hospital capacity but must address imported resistance and prescribing variation. NATO members face additional concerns related to preparedness, deployed-care environments, and continuity of infection-management capabilities.

Country Insights: National Systems Shape Appropriate Use

Australia, Canada, France, Germany, Italy, Spain, the United Kingdom, and the United States generally operate within mature regulatory, diagnostic, and stewardship environments, although prescribing patterns and resistance profiles differ by setting. Brazil, Mexico, Russia, India, China, Japan, and South Korea reflect varied combinations of hospital capacity, regulatory enforcement, laboratory access, local epidemiology, and public- and private-sector delivery. Australia, Japan, and South Korea emphasize advanced clinical infrastructure and surveillance, while India, Brazil, Mexico, China, and Russia continue to manage scale, regional variation, and access challenges. Across all listed countries, treatment decisions should follow current national guidance, susceptibility data, and approved labeling.

Actions for Leaders: Link Access, Stewardship, and Evidence

Industry leaders should prioritize evidence generation that addresses clinically relevant pathogens, resistant infections, patient safety, and real-world treatment outcomes. They should strengthen partnerships with laboratories and health systems, support high-quality antimicrobial-use and resistance surveillance, and provide clear education on indication, contraindications, interactions, and monitoring. Operational priorities include reliable supply, responsible distribution, transparent safety communication, and rapid pharmacovigilance. Leaders should also evaluate AI tools against clinical and equity standards, ensuring that digital decision support remains auditable and aligned with antimicrobial-stewardship objectives.

Research Methodology: Evidence-Led Qualitative Synthesis

This executive summary uses the defined market scope of fourth-generation fluoroquinolones and organizes the assessment across clinical, regulatory, epidemiological, technological, and geographic dimensions. The analysis emphasizes established evidence themes, including antimicrobial resistance, stewardship, diagnostics, safety monitoring, health-system capacity, and responsible adoption. Regional, group, and country discussion reflects structural differences in healthcare delivery and policy environments rather than market estimates. Claims should be validated against current regulatory documents, treatment guidelines, resistance-surveillance reports, peer-reviewed studies, and national public-health sources before operational use.

Conclusion: Responsible Positioning Is the Central Strategic Imperative

The future role of fourth-generation fluoroquinolones will depend less on broad availability alone than on precise clinical positioning, dependable diagnostics, resistance containment, and sustained safety oversight. Differences among regions, multinational groups, and countries require locally informed implementation, while common principles-appropriate indication, evidence-based duration, monitoring, and stewardship-remain universal. Organizations that integrate clinical evidence, surveillance, digital tools, and equitable access will be better placed to support effective treatment while protecting the long-term utility of this antibiotic class.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Fourth Generation Fluoroquinolones Market, by Product Type

  • 7.1. Introduction
  • 7.2. Delafloxacin
  • 7.3. Gatifloxacin
  • 7.4. Gemifloxacin
  • 7.5. Moxifloxacin

8. Fourth Generation Fluoroquinolones Market, by Route Of Administration

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Ophthalmic
  • 8.4. Oral

9. Fourth Generation Fluoroquinolones Market, by Application

  • 9.1. Introduction
  • 9.2. Eye Infections
  • 9.3. Gastrointestinal Infections
  • 9.4. Respiratory Infections
  • 9.5. Skin And Soft Tissue Infections
  • 9.6. Urinary Tract Infections

10. Fourth Generation Fluoroquinolones Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacy
    • 10.2.1. Inpatient Pharmacy
    • 10.2.2. Outpatient Pharmacy
  • 10.3. Online Pharmacy
    • 10.3.1. Hospital E-Pharmacy
    • 10.3.2. Third-Party E-Pharmacy
  • 10.4. Retail Pharmacy
    • 10.4.1. Chain Pharmacy
    • 10.4.2. Independent Pharmacy

11. Fourth Generation Fluoroquinolones Market, by End User

  • 11.1. Introduction
  • 11.2. Clinics
    • 11.2.1. Diagnostic Clinics
    • 11.2.2. Primary Care Clinics
  • 11.3. Home Care Settings
    • 11.3.1. Caregiver Administration
    • 11.3.2. Self Administration
  • 11.4. Hospitals
    • 11.4.1. Private Hospitals
    • 11.4.2. Public Hospitals

12. Fourth Generation Fluoroquinolones Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Fourth Generation Fluoroquinolones Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Fourth Generation Fluoroquinolones Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Bayer Aktiengesellschaft
  • 16.2. Bristol-Myers Squibb Company
  • 16.3. Cipla Limited
  • 16.4. Dr. Reddy's Laboratories Limited
  • 16.5. GlaxoSmithKline plc
  • 16.6. Pfizer Inc.
  • 16.7. Sandoz International GmbH
  • 16.8. Sun Pharmaceutical Industries Limited
  • 16.9. Teva Pharmaceutical Industries Limited
  • 16.10. Viatris Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Fourth Generation Fluoroquinolones Market, Years Considered for the Study
  • FIGURE 2. Global Fourth Generation Fluoroquinolones Market, Research Design
  • FIGURE 3. Global Fourth Generation Fluoroquinolones Market, Research Framework
  • FIGURE 4. Global Fourth Generation Fluoroquinolones Market, Data Triangulation
  • FIGURE 5. Global Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Fourth Generation Fluoroquinolones Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Fourth Generation Fluoroquinolones Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2025 vs 2032 (%)
  • FIGURE 9. Global Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Fourth Generation Fluoroquinolones Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Fourth Generation Fluoroquinolones Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 13. Global Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Fourth Generation Fluoroquinolones Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Fourth Generation Fluoroquinolones Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Fourth Generation Fluoroquinolones Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Fourth Generation Fluoroquinolones Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Fourth Generation Fluoroquinolones Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Fourth Generation Fluoroquinolones Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Fourth Generation Fluoroquinolones Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Fourth Generation Fluoroquinolones Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Fourth Generation Fluoroquinolones Market Segmentation & Coverage
  • TABLE 2. Global Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Delafloxacin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Delafloxacin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Delafloxacin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Gatifloxacin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Gatifloxacin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Gatifloxacin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Gemifloxacin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Gemifloxacin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Gemifloxacin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Moxifloxacin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Moxifloxacin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Moxifloxacin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 17. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Ophthalmic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Ophthalmic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Ophthalmic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Oral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Oral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Oral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 27. Global Eye Infections Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Eye Infections Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Eye Infections Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Gastrointestinal Infections Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Gastrointestinal Infections Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Gastrointestinal Infections Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Skin And Soft Tissue Infections Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Skin And Soft Tissue Infections Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Skin And Soft Tissue Infections Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Urinary Tract Infections Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Urinary Tract Infections Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Urinary Tract Infections Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 43. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Inpatient Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Inpatient Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Inpatient Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Outpatient Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Outpatient Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Outpatient Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Hospital E-Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Hospital E-Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Hospital E-Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Third-Party E-Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Third-Party E-Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Third-Party E-Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Chain Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Chain Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Chain Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Independent Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Independent Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Independent Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 71. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Diagnostic Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Diagnostic Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Diagnostic Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Primary Care Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Primary Care Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Primary Care Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Caregiver Administration Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Caregiver Administration Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Caregiver Administration Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Self Administration Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Self Administration Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Self Administration Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 92. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Fourth Generation Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 100. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 101. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 102. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 103. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 104. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 105. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 106. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 107. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 108. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 109. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 111. North America Fourth Generation Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. North America Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 113. North America Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 114. North America Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 115. North America Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 116. North America Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 117. North America Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 118. North America Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 119. North America Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 120. North America Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 121. North America Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 122. North America Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 123. Latin America Fourth Generation Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 124. Latin America Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 125. Latin America Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 126. Latin America Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 127. Latin America Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 128. Latin America Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 129. Latin America Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 130. Latin America Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 131. Latin America Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 132. Latin America Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 133. Latin America Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 134. Latin America Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 135. Europe Fourth Generation Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 136. Europe Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 137. Europe Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 138. Europe Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 139. Europe Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 140. Europe Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 141. Europe Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 142. Europe Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 143. Europe Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 144. Europe Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 145. Europe Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 146. Europe Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 147. Middle East Fourth Generation Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 148. Middle East Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 149. Middle East Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 150. Middle East Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 151. Middle East Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 152. Middle East Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 153. Middle East Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 154. Middle East Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 155. Middle East Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. Middle East Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 157. Middle East Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 158. Middle East Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 159. Africa Fourth Generation Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 160. Africa Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 161. Africa Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 162. Africa Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 163. Africa Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 164. Africa Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 165. Africa Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 166. Africa Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 167. Africa Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 168. Africa Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 169. Africa Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 170. Africa Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 171. Global Fourth Generation Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 172. ASEAN Fourth Generation Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 173. ASEAN Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 174. ASEAN Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 175. ASEAN Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 176. ASEAN Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 177. ASEAN Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 178. ASEAN Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 179. ASEAN Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 180. ASEAN Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. ASEAN Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 182. ASEAN Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 183. ASEAN Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 184. GCC Fourth Generation Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 185. GCC Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 186. GCC Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 187. GCC Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 188. GCC Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 189. GCC Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 190. GCC Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 191. GCC Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 192. GCC Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 193. GCC Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 194. GCC Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 195. GCC Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 196. European Union Fourth Generation Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 197. European Union Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 198. European Union Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 199. European Union Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. European Union Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 201. European Union Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 202. European Union Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 203. European Union Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 204. European Union Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 205. European Union Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 206. European Union Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 207. European Union Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 208. BRICS Fourth Generation Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 209. BRICS Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 210. BRICS Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 211. BRICS Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 212. BRICS Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 213. BRICS Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 214. BRICS Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 215. BRICS Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 216. BRICS Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 217. BRICS Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 218. BRICS Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 219. BRICS Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 220. G7 Fourth Generation Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 221. G7 Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 222. G7 Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 223. G7 Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 224. G7 Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 225. G7 Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 226. G7 Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 227. G7 Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 228. G7 Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 229. G7 Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 230. G7 Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 231. G7 Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 232. NATO Fourth Generation Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 233. NATO Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 234. NATO Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 235. NATO Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 236. NATO Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 237. NATO Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 238. NATO Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 239. NATO Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 240. NATO Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 241. NATO Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 242. NATO Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 243. NATO Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 244. Global Fourth Generation Fluoroquinolones Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 245. United States Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • TABLE 246. United States Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 247. United States Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 248. United States Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 249. United States Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 250. United States Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 251. United States Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 252. United States Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 253. United States Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 254. United States Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 255. United States Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 256. United States Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 257. Canada Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • TABLE 258. Canada Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 259. Canada Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 260. Canada Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 261. Canada Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 262. Canada Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 263. Canada Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 264. Canada Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 265. Canada Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 266. Canada Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 267. Canada Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 268. Canada Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 269. Mexico Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • TABLE 270. Mexico Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 271. Mexico Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 272. Mexico Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 273. Mexico Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 274. Mexico Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 275. Mexico Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 276. Mexico Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 277. Mexico Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 278. Mexico Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 279. Mexico Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 280. Mexico Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 281. Brazil Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • TABLE 282. Brazil Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 283. Brazil Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 284. Brazil Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 285. Brazil Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 286. Brazil Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 287. Brazil Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 288. Brazil Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 289. Brazil Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 290. Brazil Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 291. Brazil Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 292. Brazil Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 293. United Kingdom Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • TABLE 294. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 295. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 296. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 297. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 298. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 299. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 300. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 301. United Kingdom Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 302. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 303. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 304. United Kingdom Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 305. Germany Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • TABLE 306. Germany Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 307. Germany Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 308. Germany Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 309. Germany Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 310. Germany Fourth Generation Fluoroquinolones Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 311. Germany Fourth Generation Fluoroquinolones Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 312. Germany Fourth Generation Fluoroquinolones Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 313. Germany Fourth Generation Fluoroquinolones Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 314. Germany Fourth Generation Fluoroquinolones Market Size, by Clinics, 2017-2032 (USD Million)
  • TABLE 315. Germany Fourth Generation Fluoroquinolones Market Size, by Home Care Settings, 2017-2032 (USD Million)
  • TABLE 316. Germany Fourth Generation Fluoroquinolones Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 317. France Fourth Generation Fluoroquinolones Market Size, 2017-2032 (USD Million)
  • TABLE 318. France Fourth Generation Fluoroquinolones Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 319. France Fourth Generation Fluoroquinolones Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 320. France Fourth Generation Fluoroquinolones Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 321. France Fourth Generation Fluoroquinolones Market Size, by Distribution Channel, 2017-2032